Neuromodulation Market

Global Neuromodulation Market Analysis by Type (Internal, External, Application (Tremor, Epilepsy, Parkinson's Disease, Depression, Gastroparesis), and Region - Forecast to 2030

This Report includes
  • Executive Summary
  • Infographic Overview
  • Interactive Databook
  • Report PDF
  • PowerPoint Presentation
  • Previous Editions

Global Neuromodulation Market Overview

The report by Global Infi Research on the Neuromodulation Market examines historical sales data and thoroughly analyzes the global Neuromodulation industry. The report provides a comprehensive analysis, segmenting sales by market value and volume at the global, regional, and country levels.

This study presents an in-depth analysis of the worldwide Neuromodulation landscape, shedding light on crucial trends related to product segmentation, company establishment, revenue, market share, latest developments, and M&A activities. Additionally, it scrutinizes the strategies employed by leading global players, focusing on their Neuromodulation portfolios and capabilities, market entry approaches, market positions, and geographical footprints. This approach aims to enhance understanding of these companies' distinct positions in a rapidly evolving global Neuromodulation market.

Further, as per the analysis, the Neuromodulation market is expected to reach USD 10.20 billion by 2030 growing at a CAGR of 11.8% during the forecast period 2024 to 2030.

Who are the key players included in this report?

The major players included in this report are Abbott, Aleva, Neurotherapeutics SA., Boston Scientific Corporation, LivaNova, Medtronic, MicroTransponder, Neuronetics, NeuroPace Inc., NeuroSigma, and Nevro Corporation

The study is an in-depth analysis of emerging trends, market dynamics; growth factors, restraints, and opportunities that are going to shape the industry. The report is an exhaustive study that sheds light on market segments, regional analysis, and competitive landscape. The major 3 areas covering market share, revenue, and growth rate are determined to identify leading segments at regional and country levels.

What is the market segmentation covered in the report?

By Type

  • Internal Neuromodulation
  • External Neuromodulation

By Application

  • Chronic Pain
  • Urinary And Fecal Incontinence
  • Migraine
  • Failed Back Syndrome
  • Parkinson Disease
  • Epilepsy
  • Tremor
  • Depression
  • Other Applications

By Biomaterial

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials

How is the market segmented at the regional and country level?

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). The regions are further bifurcated at the country level to understand growth opportunities for the following:

Countries Covered
North America
U.S., and Canada
U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe
Asia Pacific
China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific
Latin America
Brazil, Mexico, and the Rest of Latin America
Middle East & Africa
GCC, Turkey, South Africa, and Rest of MEA

The neuromodulation report is an overview of emerging trends at the global and regional levels. The scope of the report is not just limited to supply and demand but also cost, price, and production analysis giving the readers an insight into past trends and prospects of the Neuromodulation industry.

The Neuromodulation market report details information on leading players & their strategic analysis, pricing trends, and micro and macro-economic factors for the period 2019-2030. The report is a holistic overview of the market situations such as market share, size (value and volume), and leading segments. Additionally, the major activities of key players such as major partnerships, mergers & acquisitions, along with technical advancements and government regulations are thoroughly reviewed in this report.

How the 2024 Neuromodulation market report will help Industry Stakeholders?

  • Current market size analysis (2023), historic data analysis (2019-2022), and market forecast for seven years (2024-2030)
  • Top market developments, M&A activities, joint ventures, and partnerships happened in the last 3 years
  • Key players dominating the Neuromodulation market, market landscape, and overview of strategies deployed by these players
  • Top performing segmental analysis and their market share breakdown at global, regional, and country level
  • Covid-19 pandemic impact and analysis
  • Analysts’ perspective on the market outlook for the next 7 years

What is the research methodology deployed for the Neuromodulation market report?

We follow a triangulated approach which comprises secondary research, primary research, and professionals’ validation to get the most effective information.

Secondary Research: secondary research is carried out to collect the quantitative and qualitative data of the Neuromodulation market. The secondary sources include annual reports, industry journals, statistical databases, and white papers among others.

Primary Research: primary research is carried out to validate the data collected through secondary sources. This method involves primary interviews with key opinion leaders and industry professionals to collect first-hand information on the market size, market trends, and competitive landscape.

Then, the market projections are validated by the experts which comprises of C-level executives of the industry. The roles considered for the experts are marketing managers, and product managers, among others.

What are the general research sources of the Neuromodulation market report?

  • White papers
  • Factiva, Bloomberg, D&B Hoovers among others
  • Industry Specific Journals
  • Company Website & Annual Reports
  • Company Press Release and News
  • Trade Organizations
  • Consumer Surveys

The report presents key market trends, drivers, and influencing factors that shape the global outlook for Neuromodulation. Furthermore, it breaks down forecasts by type, application, geography, and market size, giving an idea about prevailing opportunities.

The study employs a transparent methodology grounded in numerous bottom-up qualitative and quantitative market inputs, providing a highly nuanced perspective on the present state and future course of the global Neuromodulation market.

To conclude, the report evaluates geographical segments of the market and analyses the competitive landscape of leading players in the industry, including cost and revenue analysis, growth factors, trends, and future forecasts. The report also evaluates the Neuromodulation market on growth matrix analysis, SWOT and PESTLE, and Five Forces analysis to evaluate market potential and growth factors. This report can help key stakeholders to get insights on investment feasibility into different avenues of the industries and investment return factors analyzed thoroughly.

Table of Contents

Section 1: Introduction 

Section 2: Research Methodology

Section 3: Executive Summary

Section 4: Market Dynamics - Neuromodulation Market Industry Insights

Section 5: Market Segmentation - Global Neuromodulation Market

  • By Type
  • By Application
  • By Biomaterial

Section 6: Geographical Analysis - Global Neuromodulation Market

  • By Global
  • By Regional 
  • By Country Level

Section 7: Competitive Landscape

Section 8: Company Profiles - Neuromodulation Market

Section 9: COVID-19 Impact

Section 10: Key Success Factors and Market Conclusion

What should be an effective go-to-market strategy that delivers exceptional results?